Integra LifeSciences (NASDAQ: IART) reported Q1 EPS of $0.74, $0.01 better than the analyst estimate of $0.73. Revenue for the quarter came in at $236.8 million versus the consensus estimate of $230.66 million.

GUIDANCE:

Integra LifeSciences sees FY2016 EPS of $3.38-$3.50, versus prior guidance of $3.35-$3.50 and the consensus of $3.43. Integra LifeSciences sees FY2016 revenue of $985-1000 million, versus prior guidance of $975-1000 million and the consensus of $987.0 million.

For earnings history and earnings-related data on Integra LifeSciences (IART) click here.